Infectious Diseases – Webinars and Online Events

Speaking at the Vaccine Research & Development 2022, Jorge Armero Gimenez from Wageningen University & Research, presented their talk on Virus-Like Particles immunogenicity in human dendritic cells.

Histology has a crucial role throughout the drug discovery and development pipeline, from early-stage R&D to clinical trials.

In this webinar, we will cover time-saving tips to help increase your PCR productivity. We will address common PCR pitfalls that can be avoided with innovations in enzymes, instruments, and plastics. We will also discuss PCR tools that are available to researchers who wish to push PCR boundaries to overcome research limitations.

Speaking at Advances in proteomics & Metabolomics 2022, Iulia Macavei from Université de Lyon, presented their talk on antimicrobial resistance.

In this webinar, Dr. Catherine Houlihan, will describe an unrecognized case of viral hemorrhagic fever imported into the UK and the important lessons learned for the emergency clinicians, GPs, virologists, infection specialists and public health doctors.

Over recent years, genomic sequencing of pathogens has emerged as a powerful tool to guide public health action by providing a deeper understanding of pathogen evolution, emerging variants and transmission dynamics. Oxford Nanopore Technologies offers an accessible, all-in-one sequencing platform that enables rapid, distributed and scalable genomic pathogen surveillance.

In this webinar, you will hear from leaders in the field of microbiology and infectious disease research, who will share their experiences in developing and implementing fast and accessible pathogen surveillance protocols with nanopore sequencing. The protocols presented in this webinar can be leveraged for targeted whole genome sequencing of different viral pathogens such as SARS-CoV-2 and monkeypox virus, as well as more broadly for the genomic characterization of known and novel viruses in an untargeted manner.

Kevin Coombs, PhD, is a professor of medical microbiology and infectious diseases. Research from Dr. Coomb’s group involving the screening of over 1300 host proteins in Zika virus-infected cells.

This inaugural online symposium will provide a unique opportunity to hear from experts within academia and industry. The focus will be given to advances and innovations that are driving vaccine R&D, with process challenges and bottlenecks also discussed.

In this third and final part of our translational cell and gene therapy webinar series we delve into cell therapy applications beyond immune oncology.

In this webinar, we will explore the common challenges encountered by developers and manufacturers when developing PCR tests, and how these challenges can be overcome with the right technologies.